Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Tyme Technologies to Present at the Ladenburg Thalmann 2019 Healthcare Conference on September 24, 2019 | ||
By: Nasdaq / GlobeNewswire - 17 Sep 2019 | Back to overview list |
|
NEW YORK, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present at the Ladenburg Thalmann 2019 Healthcare Conference on Tuesday, September 24, 2019. The Company will present its corporate overview for 2019 with a special focus on growth opportunities driven by advancements in the science of cancer metabolism and clinical developments for its lead candidate SM-88 (racemetyrosine) in pancreatic, prostate, and sarcoma cancers. Event: Ladenburg Thalmann 2019 Healthcare Conference A live webcast of the presentation will be accessible on the events page under the Investor Relations section of Tyme Technologies’ website at www.tymeinc.com. About Tyme Technologies Forward-Looking Statements/Disclosure Notice The information contained in this press release is as of release date and TYME assumes no obligation to update forward-looking statements contained in this release as a result of future events or developments. For Investor Relations & Media Inquiries: Contact: |
||
|
||
Copyright 2019 Nasdaq / GlobeNewswire | Back to overview list |